Related Experiment Video
Updated: Jun 2, 2026
14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.8K
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform
Farzaneh Nikparast1, Zohreh Ganji1, Mohammad Danesh Doust1
1Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Insights Into Imaging
|April 13, 2022
Summary
Quantitative susceptibility mapping (QSM) offers a reliable, non-invasive method for assessing brain iron deposition. This magnetic resonance imaging technique shows promise for diagnosing neurodegenerative diseases by quantifying iron accumulation.
Area of Science:
- Neuroimaging
- Biomedical Engineering
- Neurology
Background:
- Iron is vital for biological functions but excess brain deposition causes neurological issues.
- Neurodegenerative diseases are often associated with abnormal iron accumulation.
- Accurate assessment of brain iron is crucial for diagnosis and management.
Purpose of the Study:
- To evaluate Quantitative Susceptibility Mapping (QSM) against existing methods for assessing brain iron deposition.
- To provide a comprehensive review of QSM's performance in clinical settings.
- To discuss the role of iron in neurodegeneration and diagnostic challenges.
Main Methods:
- Narrative review of existing literature on brain iron assessment techniques.
- Comparison of Quantitative Susceptibility Mapping (QSM) with other MRI-based and conventional methods.
- Analysis of QSM's efficacy in detecting and quantifying iron in neurodegenerative conditions.
Main Results:
- QSM demonstrates high accuracy and reliability in quantifying iron deposition in the brain.
- QSM offers superior performance compared to conventional methods in specific clinical applications.
- The review highlights QSM's potential to improve the diagnosis of iron-related neurological disorders.
Conclusions:
- Quantitative Susceptibility Mapping (QSM) is a promising, non-invasive tool for clinical assessment of brain iron.
- QSM can aid in the early detection and monitoring of neurodegenerative diseases.
- Further clinical validation of QSM is warranted to establish its widespread use.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...